Jynarque 45MG
Ended Awarded Last action
- Contract number
- 36C24521F0240
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $10,299
Award facts
- Contract value 100% obligated
- $10,298.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Deerfield, IL 60015, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$5 | |
| Original award | $10,304 |
About this award
Otsuka America Pharmaceutical Inc. was awarded a delivery order valued at $10,298.57 by the Department of Veterans Affairs' Veterans Integrated Service Network 5 for Jynarque 45mg, a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia. Awarded on February 19, 2021, with completion targeted for September 20, 2021, this firm-fixed price contract represents a task order under the company's larger Blanket Purchase Agreement for Jynarque issued through the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract carries no set-aside designation and is being performed in Riverwoods, Illinois.
This delivery order supports the Veterans Health Administration's mission to provide specialized pharmaceutical treatments to veterans across the United States. Otsuka America maintains an $83.3 million Blanket Purchase Agreement with the VA's National Acquisition Center for Jynarque, along with a $396 million Federal Supply Schedule contract for pharmaceuticals and hematology-related products, positioning the company as an established supplier of critical medications to VA facilities across multiple Veterans Integrated Service Networks nationwide.
Quick answers
Who was awarded contract 36C24521F0240?
36C24521F0240 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on February 19, 2021.
How much is contract 36C24521F0240 worth?
The government has obligated $10,299 on 36C24521F0240.
Is contract 36C24521F0240 an order under another contract?
Yes. 36C24521F0240 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24521F0240 competed?
The extent of competition for 36C24521F0240 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award